4d Pharma PLC Clinical Update – Blautix IND

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, has today announced that the Company has submitted, and the U.S. Food and Drug Administration (FDA) has cleared, an Investigational New Drug Application for Blautix, the Company’s live biotherapeutic for the treatment of Irritable Bowel Syndrome (IBS). Enrolment in the Phase 2 study is expected to commence in the second half of 2018.

The double-blind, placebo-controlled multicentre Phase 2 study will evaluate the efficacy and safety of Blautix in patients with IBS with constipation (IBS-C) and IBS with diarrhoea (IBS-D). 4D has consulted with the FDA on the design of the study. Up to 500 patients will receive either Blautix or placebo daily for 8 weeks. The primary endpoint will be the Overall Response rate, defined as the proportion of patients reporting an improvement in their weekly cohort-specific symptoms (abdominal pain and stool frequency or consistency) for at least 4 out of 8 weeks. A range of secondary efficacy endpoints will also be assessed, as well as the effects of Blautix on the gut microbiome.

Dr. Alex Stevenson, 4D Pharma Plc Chief Scientific Officer, commented: “We are delighted to advance Blautix into this important proof-of-concept study, which brings us another step closer to bringing a novel treatment regime to patients. Despite affecting up to 15% of the population, and a market forecast to be worth more than $2.5 billion by 2024*, IBS is poorly addressed with current therapies, which only target the symptoms of the disease rather than tackling the underlying causes. By targeting the microbiome, Blautix has the potential to make a real difference for patients and could represent a new era in the treatment of IBS.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    4d Pharma Plc

    More articles like this

    4d Pharma Plc

    Experts Share The Real Dangers Of IBS And Pregnancy

    If you have Irritable Bowel Syndrome (IBS) or know someone who does, you know of its debilitating effects. Between abdominal cramping, constipation and/or diarrhea, IBS can make even the easiest of tasks or excursions difficult. With

    4d Pharma Plc

    How the bacteria in your gut affect your mind and body

    Have you ever felt “butterflies in your stomach,” or made a “gut decision”? That might have been your “second brain”  otherwise known as your gut  talking. Our guts are composed of over 100 trillion bacteria and

    4d Pharma Plc

    Can detoxing help your gut health?

    If you have over-indulged of late, then the idea of detox may well appeal – flushing out the Christmas and New Year excesses, and negotiating the start of the year afresh. There are plenty of products

    4d Pharma Plc

    10 signs and symptoms of irritable bowel syndrome

    Irritable bowel syndrome is a gut disorder characterized by cramps, bloating, and bouts of constipation and diarrhea, among other symptoms. Disrupted communication between the gut and brain causes the signs and symptoms of irritable bowel syndrome

    4d Pharma Plc

    What we do and don’t know about gut health

    Inside your gastrointestinal (GI) tract are trillions of micro-organisms, including bacteria, fungi and viruses. You have roughly the same number of micro-organisms in there, mostly in the large intestine, as you do human cells in your

    4d Pharma Plc

    Does bad sleep change your gut bacteria?

    We all know that not getting enough sleep is bad for you. But did you know it might be bad for all the little organisms living inside you? There are a whole bunch of bacteria and

    4d Pharma Plc

    What to Eat for a Happy, Healthy Gut

    Want to get healthier this year? Almost half of Americans resolve to. But you do not have to drastically slash your calorie intake or take up residence at the gym to improve your health. Since we